Skip to main content
TipRanks
Go Ultimate75% OFF

Viva Biotech Holdings (1873) Financial Statements

4 Followers

Viva Biotech Holdings Financial Overview

Viva Biotech Holdings's market cap is currently ¥2.43B. The company's EPS TTM is ¥0.08; its P/E ratio is 12.11; and it has a dividend yield of 0.27%. Viva Biotech Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.73B¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B
Gross Profit¥ 655.56M¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M
Operating Income¥ 193.25M¥ 229.67M¥ 192.68M¥ 269.35M¥ 236.90M
EBITDA¥ 404.30M¥ 443.53M¥ 403.90M¥ 451.35M¥ 390.06M
Net Income¥ 219.76M¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M
Balance Sheet
Cash & Short-Term Investments¥ 1.13B¥ 941.58M¥ 1.04B¥ 678.57M¥ 800.95M
Total Assets¥ 7.20B¥ 7.05B¥ 7.45B¥ 7.92B¥ 8.04B
Total Debt¥ 1.33B¥ 1.28B¥ 1.90B¥ 2.82B¥ 2.65B
Net Debt¥ 221.91M¥ 342.47M¥ 866.89M¥ 2.14B¥ 1.85B
Total Liabilities¥ 3.19B¥ 3.23B¥ 3.76B¥ 4.32B¥ 4.13B
Stockholders' Equity¥ 4.00B¥ 3.80B¥ 3.69B¥ 3.60B¥ 3.91B
Cash Flow
Free Cash Flow¥ 88.02M¥ 182.32M¥ 195.57M¥ 136.72M¥ -487.35M
Operating Cash Flow¥ 206.04M¥ 373.99M¥ 383.40M¥ 386.05M¥ 77.83M
Investing Cash Flow¥ -93.76M¥ 185.90M¥ 439.17M¥ -372.80M¥ -868.84M
Financing Cash Flow¥ 36.61M¥ -657.76M¥ -429.50M¥ -143.20M¥ -653.16M

Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

-1.5B01.5B3B-80 %0 %80 %160 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Viva Biotech Holdings Liabilities to Assets

03B6B9B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Viva Biotech Holdings Cash Flow

-5B-2.5B02.5B5B7.5B201720182019202020212022202320242025OperatingInvestingFinancing

Viva Biotech Holdings Forecast EPS vs Actual EPS

0000.10.10.1Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss